Beigene Ltd., of Waltham, Mass., part of Beigene Co. Ltd., of Beijing, appointed Ji Li executive vice president, global head of business development. Previously Li served as vice president of business development and licensing at Merck Research Laboratories, a subsidiary of Merck & Co. Inc., where he was responsible for business development activities of late-stage inbound and outbound opportunities. In addition, he led the team in executing external clinical collaborations in the immune-oncology space and Merck’s R&D business development efforts in Japan and China. Li obtained his B.S. in pharmacology from Shanghai Medical University and PhD in neuroscience from Mount Sinai School of Medicine in New York.